© 2019 Mission Bay Capital. All rights reserved.

NEWS

January 15, 2016

Roche and Catalent team up in $600m conjugation tech deal

 

January 7, 2016

Principia Biopharma Advances BTK Inhibitor Program in Autoimmune Disease and FGFR Inhibitor Program in Oncology

 

January 7, 2016

4D Molecular Therapeutics Announces Collaboration With Pfizer Inc. for Cardiac Gene Therapy Vector Discovery and Development

 

January 7, 2016

Circle Pharma Announces Receipt of Additional Seed Investment, Relocation to New Laboratory Facility and Initiation of Internal Pipeline Development

 

January 6, 2016

eFFECTOR Therapeutics Initiates Dosing in Phase 1/2 Clinical Trial of eFT508 in Solid Tumors

 

December 22, 2015

eFFECTOR Therapeutics Raises $40 Million Series B Financing

 

November 4, 2015

Gates Foundation, GSK, others back biotech in white-hot area of cancer

 

November 4, 2015

Atreca, Inc., Completes Oversubscribed $56 Million Series A Funding to Advance Pipeline of Novel Cancer Immunotherapies

 

June 16, 2015

Zymergen Grabs $44M For “Designer” Microbes Tested by Robots

 

June 3, 2015

A Bay Area Startup Spins Lab-Grown Silk

 

May 12, 2015

Bay Area Fund, Aligned With UC, Raises New Cash To Seed Biotechs

 

May 12, 2015

Small but mighty VC doubles up with new biotech seed fund

 

October 3, 2014

Catalent Expands Its Technology Offerings In Biologics, Acquires Redwood Bioscience Inc. And The SMARTag™ Technology Platform

 

April 29, 2014

Bristol-Myers Squibb Acquires iPierian, Inc.

 

October 29, 2013

Calithera BioSciences Nabs $35M for Cancer Drugs

 

May 21, 2013

Effector Therapeutics Raises $45M to Prove New Concept in Cancer

 

May 15, 2013

Bayer inks startup matchmaking deal with QB3, Mission Bay Capital

 

April 10, 2013

Catalent Biologics Expands Into ADCs Through Exclusive License With Redwood Bioscience

 

March 19, 2013

This Protein Could Change Biotech Forever

 

October 30, 2012

UCSF Spinout Principia Biopharma Thinking Big and Covalent

 

October 2, 2012

Startup Atreca Joins With Gates Foundation to Speed Vaccine Discovery

 

April 5, 2012

Mission Bay Capital Seeds Surgical Device Start-Up Magnamosis

 

September 8, 2011

Biopharma Venture Funds Are Stepping Up Where VC Firms Are Stepping Out

 

December 21, 2010

Expansion of Incubator Network, Seed Fund Among QB3 Priorities for 2011

 

September 16, 2010

New Venture Capital Firms In A Shrinking Industry (Part II)

 

July 7, 2010

Calithera, a UCSF Spinoff, Raises $40M to Develop Cancer Drugs

 

July 7, 2010

Mission Bay Capital invests in UCSF cancer therapy spinoff

 

April 26, 2010

Mission Bay Capital makes first investment, in UC biotech spinoff

 

April 25, 2010

UC targeted seed fund backs first startup

 

October 26, 2009

Mission Bay Capital Announces First Venture Fund